These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7917935

  • 1. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG, Osterlind K, Hansen HH, Cooper EH.
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC, Park KO, Kim YC, Na KJ, Song H, Bom HS.
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
    Liu X, Zhang W, Yin W, Xiao Y, Zhou C, Hu Y, Geng S.
    Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
    [Abstract] [Full Text] [Related]

  • 4. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
    Jørgensen LG, Hansen HH, Cooper EH.
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
    [Abstract] [Full Text] [Related]

  • 5. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P, Joos G, Watripont P, Brusselle G, Pauwels R.
    Respiration; 1997 Jan; 64(1):102-7. PubMed ID: 9044484
    [Abstract] [Full Text] [Related]

  • 6. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
    Peng Y, Wang Y, Li J, Hao X, Hu X.
    Zhongguo Fei Ai Za Zhi; 2016 Sep 20; 19(9):590-4. PubMed ID: 27666548
    [Abstract] [Full Text] [Related]

  • 7. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC, Worofka B, Schernthaner G, Vetter N, Neumann M, Dudczak R, Kuzmits R.
    Cancer; 1990 Mar 15; 65(6):1386-90. PubMed ID: 2155054
    [Abstract] [Full Text] [Related]

  • 8. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N, Jassem E, Bonfrer JM, Mooi WJ, van Tinteren H.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [Abstract] [Full Text] [Related]

  • 9. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
    Jørgensen LG, Osterlind K, Hansen HH, Cooper EH.
    Br J Cancer; 1988 Dec 15; 58(6):805-7. PubMed ID: 2852029
    [Abstract] [Full Text] [Related]

  • 10. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
    Fizazi K, Cojean I, Pignon JP, Rixe O, Gatineau M, Hadef S, Arriagada R, Baldeyrou P, Comoy E, Le Chevalier T.
    Cancer; 1998 Mar 15; 82(6):1049-55. PubMed ID: 9506348
    [Abstract] [Full Text] [Related]

  • 11. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
    Quoix E, Purohit A, Faller-Beau M, Moreau L, Oster JP, Pauli G.
    Lung Cancer; 2000 Nov 15; 30(2):127-34. PubMed ID: 11086206
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J, Xiong Q.
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar 15; 26(1):90-3. PubMed ID: 7657349
    [Abstract] [Full Text] [Related]

  • 13. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E, Kulpa JK, Sas-Korczyńska B, Korzeniowski S, Jakubowicz J.
    Anticancer Res; 2008 Mar 15; 28(5B):3027-33. PubMed ID: 19031951
    [Abstract] [Full Text] [Related]

  • 14. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
    Akoun GM, Scarna HM, Milleron BJ, Bénichou MP, Herman DP.
    Chest; 1985 Jan 15; 87(1):39-43. PubMed ID: 2981171
    [Abstract] [Full Text] [Related]

  • 15. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
    Giovanella L, Ceriani L, Bandera M, Garancini S.
    Int J Biol Markers; 2001 Jan 15; 16(1):50-5. PubMed ID: 11288956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
    Harding M, McAllister J, Hulks G, Vernon D, Monie R, Paul J, Kaye SB.
    Br J Cancer; 1990 Apr 15; 61(4):605-7. PubMed ID: 2158809
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
    Batandier C, Brambilla E, Nagy-Mignotte H, Laporte F, Jacrot M, Beriel H, Paramelle B, Brambilla C.
    Scand J Clin Lab Invest; 1989 Feb 15; 49(1):33-42. PubMed ID: 2543057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.